Loopworm Nets $3.3 Mn To Manufacture Recombinant Proteins

Loopworm, a startup focused on manufacturing recombinant proteins, has netted $3.3 million in funding. This investment highlights growing interest in biotechnology and sustainable protein production. Recombinant proteins have diverse applications in pharmaceuticals, agriculture, and food industries. The capital will likely be used to scale Loopworm's production capabilities, advance its research and development, and expand its market reach. This funding signifies investor confidence in Loopworm's innovative approach to protein manufacturing, which could offer more sustainable and efficient alternatives to traditional methods, addressing critical needs in various high-growth sectors and contributing to a circular economy.